Dall’Olio, Filippo G.
Marabelle, Aurélien http://orcid.org/0000-0002-5816-3019
Caramella, Caroline
Garcia, Camilo http://orcid.org/0000-0002-4201-1862
Aldea, Mihaela
Chaput, Nathalie
Robert, Caroline http://orcid.org/0000-0002-9493-0238
Besse, Benjamin
Article History
Accepted: 10 September 2021
First Online: 12 October 2021
Competing interests
: A.M. has acted as an adviser and/or consultant of Amgen, AstraZeneca/Medimmune, BMS, GSK, IMCheck, J&J, Merck (MSD), Merck Serono, OSE immunotherapeutics, Pfizer, Pierre Fabre, Roche/Genentech, Sanofi and Symphogen/Servier, has received travel support from AstraZeneca, BMS, Merck (MSD) and Roche, and has received research funding from BMS, Boehringer Ingelheim, Fondation MSD Avenir, Merus and Transgene. C.C. has acted as a consultant of AstraZeneca, BMS, MSD and Roche. N.C. has received research funding from AstraZeneca, BMS Foundation, Cytune pharma, GSK and Roche. C.R. has acted as a consultant of Amgen, BMS, MSD, Novartis, Pfizer, Pierre Fabre, Roche and Sanofi. B.B. has conducted research funded by Abbvie, Amgen, Aptitude Health, AstraZeneca, Beigene, Biogen, Blueprint Medicines, BMS, Boehringer Ingelheim, Celgene, Cergentis, Cristal Therapeutics, Daiichi-Sankyo, Eli Lilly, GSK, Ignyta, Inivata, Ipsen, Merck, MSD, Nektar, Onxeo, OSE immunotherapeutics, Pfizer, Pharma Mar, Roche-Genentech, Sanofi, Spectrum Pharmaceuticals, Takeda,Tiziana Pharm 4D Pharma and Tolero Pharmaceuticals.